000 01574 a2200409 4500
005 20250516070801.0
264 0 _c20120821
008 201208s 0 0 eng d
022 _a1432-1041
024 7 _a10.1007/s00228-011-1171-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrennan, Meghan
245 0 0 _aMeta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_cMay 2012
300 _a645-55 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
650 0 4 _aAngiogenesis Inhibitors
_xblood
650 0 4 _aAxitinib
650 0 4 _aBiological Transport
650 0 4 _aBiotransformation
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aCytochrome P-450 Enzyme System
_xgenetics
650 0 4 _aHumans
650 0 4 _aImidazoles
_xblood
650 0 4 _aIndazoles
_xblood
650 0 4 _aIsoenzymes
_xgenetics
650 0 4 _aOrganic Anion Transporters
_xgenetics
650 0 4 _aPolymorphism, Genetic
650 0 4 _aReceptors, Vascular Endothelial Growth Factor
_xantagonists & inhibitors
700 1 _aWilliams, J Andrew
700 1 _aChen, Ying
700 1 _aTortorici, Michael
700 1 _aPithavala, Yazdi
700 1 _aLiu, Yingxue Cathy
773 0 _tEuropean journal of clinical pharmacology
_gvol. 68
_gno. 5
_gp. 645-55
856 4 0 _uhttps://doi.org/10.1007/s00228-011-1171-8
_zAvailable from publisher's website
999 _c21392237
_d21392237